or search for allinseo plug in" Body Health Advisor » Blog Archive » Advice on Health and Body Matters

Overweight and suffering from Back Pain?

If your overweight, you may be experiencing back pain.

Traditional medical wisdom has long stated that the firmer the mattress, the better it’s for back pain sufferers.

Now, a Spanish scientific study- published in the prestigious British medical journal The Lancet on November 2003 - strongly suggests that traditional wisdom is wrong.

The study, conducted by Francisco Kovacs of Kovacs Foundation in Palma de Mallorca, has analyzed 313 people with cronic non-specific low back pain, that sleeped on mattresses with different levels of firmness.

After 90 days, the results showed that the medium-firm mattresses outscored the firmer ones by a significant margin, a definitive response and a definitive debunking of traditional wisdom.

But, more important, the study also showed that sleeping on a new mattress, whether it’s very firm or medium-firm, rather than an old one, was associated with more frequent discontinuation of drug treatment and relevant improvement in pain and disability. So, we have the scientific support that replacing an old mattress with a new one can improve back pain.

These results have been recently confirmed by a new, groundbreaking study “Subjective Rating of Perceived Back Pain, Stiffness and Sleep Quality Following Introduction of Medium-Firm Bedding System,” published in the Journal of Chiropractic Medicine (Winter 2006), authored by Bert Jacobson, EdD, Tia Wallace, MS, and Hugh Gemmell, DC, EdD of Oklahoma State University.

The study shows the critical link between mattress quality and sleep quality, as well as the importance of regular mattress replacement. In fact a new mattress, compared to a 5-7 years old ones, improves sleep quality by 62% and sleep comfort by 70.8%, plus reduced back pain by 55.3% and back stiffness by 50.7% over a four week period. The study has also found that lower back pain was much more prominent for people who sleep on cheaper beds and older beds.

So please, don’t let anyone tell you that sleeping through the night is a luxury: a good night’s sleep is essential to great health! Here are some number.

Recent statistics say 70 millions Americans are affected by sleep problems and the latest scientific researches suggest that our life could depend on sleeping well. Even minor sleep deficits rocket your production of stress hormones. Sleeping less than 6 hours can raise the risk of numerous health problems. Some examples?

An healthy night’s sleep can help your body: manage stress and maintain healthy blood sugar, because sleep deficits increase the levels of cortisol and other stress hormones, and this can have a negative impact on healthy blood sugar levels too; stay at a healthy weight because some studies show that adults who sleep the least appear to be the most likely to gain weight, because sleep deprivation increases levels of two critical hormones involved in regulating food intake - ghrelin and leptin - and this may lead to overeating and weight gain.

Now, we’ve scientific proofs that a new, high quality mattress leads to a good night’s sleep and this leads to an healthier and more productive life. The mattress should be one of the most important investment we ever make…don’t sleep on it!

Oliverio Abitrante - Materassi Sogni d’oro - http://www.materassisognidoro.it

Technorati Tags:

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

  • Kombiglyze XR as a treatment for type 2 diabetes in adults approved
    Bristol-Myers, AstraZeneca Receive FDA Approval For Diabetes Drug. The AP (11/5) reported, “Drug makers Bristol-Myers Squibb Co. and AstraZeneca PLC said Friday that they received US marketing approval for a once-a-day diabetes drug that combines the starter diabetes drug metformin with the companies’ newer drug Onglyza.” The Food and Drug […]
  • Type 2 Diabetes is increasing in China
    Global research and advisory firm Decision Resources has predicted that the Chinese type 2 diabetes market will grow from $1.4 billion in 2009 to $2.5 billion in 2014. According to the Emerging Markets report entitled Type 2 Diabetes in China, this growth is attributed to an increasing drug-treated population, expanding medical insurance coverage and the [.. […]
  • Avastatin for Breast cancer
    Roche Stands To Lose Substantial Sales Should Regulatory Bodies Revoke License For Avastin. Dow Jones Newswire(12/8, Mijuk) reported that should FDA and European regulators revoke the license for Avastin (bevacizumab) as a treatment for breast cancer, then the drug’s maker, Roche Holding AG, may stand to lose more than one billion Swiss francs in sales […]
  • FDA: Tainted products marketed as dietary supplements potentially dangerous
    Agency working with trade associations to increase company vigilance and protect public In a letter sent today to dietary supplement manufacturers, the U.S. Food and Drug Administration expressed concern about undeclared or deceptively labeled ingredients in products marketed as dietary supplements. These substances include the active ingredients in FDA-a […]
H1N1 Fraudulent Products update







Tai Chi WeightLoss